1. |
De Silva MJ, Roberts I, Perel P, Edwards P, Kenward MG, Fernandes J, et al. Patient outcome after traumatic brain injury in high-, middle- and low-income countries: Analysis of data on 8927 patients in 46 countries. Int J Epidemiol 2009;38:452-8.
|
2. |
Rahimi-Movaghar V, Saadat S, Rasouli MR, Ghahramani M, Eghbali A. The incidence of traumatic brain injury in Tehran, Iran: A population based study. Am Surg 2011;77:e112-4.
|
3. |
Perel P, Al-Shahi Salman R, Kawahara T, Morris Z, Prieto-Merino D, Roberts I, et al. CRASH-2 (Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage) intracranial bleeding study: The effect of tranexamic acid in traumatic brain injury – A nested randomised, placebo-controlled trial. Health Technol Assess 2012;16:i-54.
|
4. |
Roberts I, Yates D, Sandercock P, Farrell B, Wasserberg J, Lomas G, et al. Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): Randomised placebo-controlled trial. Lancet 2004;364:1321-8.
|
5. |
Narayan RK, Maas AI, Servadei F, Skolnick BE, Tillinger MN, Marshall LF, et al. Progression of traumatic intracerebral hemorrhage: A prospective observational study. J Neurotrauma 2008;25:629-39.
|
6. |
Oertel M, Kelly DF, McArthur D, Boscardin WJ, Glenn TC, Lee JH, et al. Progressive hemorrhage after head trauma: Predictors and consequences of the evolving injury. J Neurosurg 2002;96:109-16.
|
7. |
Zehtabchi S, Abdel Baki SG, Falzon L, Nishijima DK. Tranexamic acid for traumatic brain injury: A systematic review and meta-analysis. Am J Emerg Med 2014;32:1503-9.
|
8. |
Jokar A, Ahmadi K, Salehi T, Sharif-Alhoseini M, Rahimi-Movaghar V. The effect of tranexamic acid in traumatic brain injury: A randomized controlled trial. Chin J Traumatol 2017;20:49-51.
|
9. |
CRASH-2 Trial Collaborators, Shakur H, Roberts I, Bautista R, Caballero J, Coats T, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): A randomised, placebo-controlled trial. Lancet 2010;376:23-32.
|
10. |
Du CN, Liu BX, Ma QF, Yang MF. The effect of tranexamic acid in patients with TBI: A systematic review and meta-analysis of randomized controlled trials. Chin Neurosurg J 2020;6:14.
|
11. |
Nelson Yap KB, Albert Wong SH, Idris Z. Tranexamic acid in traumatic brain injury. Med J Malaysia 2020;75:660-5.
|
12. |
Samadi-Motlagh P, Shimia M, Shakeri M, Mohammadzadeh A, Salehpour F, Mahdkhah A, et al. Role of tranexamic acid in treatment of patients with epidural hematoma. Iran J Neurosurg 2016;2:8-10.
|
13. |
Fakharian E, Abedzadeh-Kalahroudi M, Atoof F. Effect of tranexamic acid on prevention of hemorrhagic mass growth in patients with traumatic brain injury. World Neurosurg 2018;109:e748-53.
|
14. |
Mahmood A, Needham K, Shakur-Still H, Harris T, Jamaluddin SF, Davies D, et al. Effect of tranexamic acid on intracranial haemorrhage and infarction in patients with traumatic brain injury: A pre-planned substudy in a sample of CRASH-3 trial patients. Emerg Med J 2021;38:270-8.
|
15. |
Yutthakasemsunt S, Kittiwatanagul W, Piyavechvirat P, Thinkamrop B, Phuenpathom N, Lumbiganon P. Tranexamic acid for patients with traumatic brain injury: A randomized, double-blinded, placebo-controlled trial. BMC Emerg Med 2013;13:20.
|
16. |
Rowell SE, Meier EN, McKnight B, Kannas D, May S, Sheehan K, et al. Effect of out-of-hospital tranexamic acid versus placebo on 6-month functional neurologic outcomes in patients with moderate or severe traumatic brain injury. JAMA 2020;324:961-74.
|
17. |
Yokobori S, Yatabe T, Kondo Y, Kinoshita K, Japan Resuscitation Council (JRC) Neuroresuscitation Task Force and the Guidelines Editorial Committee. Efficacy and safety of tranexamic acid administration in traumatic brain injury patients: A systematic review and meta-analysis. J Intensive Care 2020;8:46.
|
18. |
CRASH-3 trial collaborators. Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): A randomised, placebo-controlled trial. Lancet 2019;394:1713-23.
|
19. |
Roos YB, Rinkel GJ, Vermeulen M, Algra A, van Gijn J. Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 2003;(2):CD001245.
|
20. |
Chakroun-Walha O, Samet A, Jerbi M, Nasri A, Talbi A, Kanoun H, et al. Benefits of the tranexamic acid in head trauma with no extracranial bleeding: A prospective follow-up of 180 patients. Eur J Trauma Emerg Surg 2019;45:719-26.
|